TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Elan-J&J Deal Breaches Pact, Judge Rules A federal judge has ruled that Elan's recent deal with Johnson & Johnson breaches its nine-year collaboration with Biogen Idec to sell Tysabri. online.barrons.com |
Race for Obesity Drugs Heats Up Arena reported a successful late-stage trial of its weight-loss drug, but Vivus is still considered the leader as three companies race to deliver a new, viable drug to fight obesity. online.barrons.com |
NeoGenomics Schedules Its Q3 2009 Earnings Release for October 29, 2009 (PR Newswire) NeoGenomics, Inc. announced today that it plans to release its third quarter 2009 financial results on Thursday, October 29, 2009. us.rd.yahoo.com |
Roche says FDA grants approval for swine flu test (AP) Swiss drug giant Roche said Monday that U.S. health regulators granted emergency approval to its diagnostic test for the 2009 swine flu. us.rd.yahoo.com |
Two Biotech Companies that Make 'Green Sense' Marc Courtenay submits:In the spirit of such laconic writers as David Fry and Lou Basenes (who can say a great deal in just a few paragraphs) I want to share with you two examples of how biotechnology company can be fiscally "green" and as well as responisble. The one whose trademark you see above, Genoptix (Nasdaq:GXDX) impresses me so much I bought some Thursday at around $35.81. I like what it does, I like its profit and operating margins, I like the fact that it has no debt, and I like the fact that it has over $137 million dollar in cash sitting on its balance sheet.Complete Story » seekingalpha.com |